Novel Insights from Clinical Practice

Grover C.a· Saha S.a· Sharma S.b

Author affiliations

aDepartment of Dermatology and STD, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India
bDepartment of Pathology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: January 09, 2022
Accepted: February 25, 2022
Published online: May 24, 2022

Number of Print Pages: 5
Number of Figures: 5
Number of Tables: 1

ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)

For additional information: https://www.karger.com/SAD

Abstract

Introduction: Irritant contact dermatitis affecting the nail unit may lead to nail matrix damage and onychomadesis, which may initially be subclinical, becoming overt later. We describe a patient who developed these changes after using a chemical pesticide. Case Presentation: A 52-year-old woman presented with discoloration of the nails of both hands of two days' duration, associated with mild digital pain. She had used an over-the-counter insecticide product containing thiamethoxam (a broad-spectrum systemic insecticide) for her houseplants, preceding the nail changes. Examination revealed onycholysis and subclinical onychomadesis involving multiple fingernails as well as toenails. Onychoscopic examination showed proximal nail plate separation with an erythematous regular border. Histopathology showed an essentially normal nail plate with spongiosis, epidermal cell necrosis, and hypergranulosis. However, there was no evidence of bacterial or fungal infection, and dermal inflammation was mild. The patient was diagnosed with thiamethoxam-induced irritant dermatitis with subclinical onychomadesis and was advised to take general precautions with avoidance of any further contact with the insecticide. She was managed with topical steroids and emollient; however, on follow-up, she developed green nails, with progression to overt onychomadesis in some nails. Additionally, onychomycosis was observed in few nails in the long-term, which needed to be treated. Conclusion: Thiamethoxam is an over-the-counter broad-spectrum insecticide used for houseplants, but its safety data does not mention acute adverse effects on nails, which was a novel finding in our patient. The safety data does mention the use of gloves for preparing and administering the product. Secondary bacterial and fungal infections, which can occur after the initial insult, further worsen the prognosis.

© 2022 S. Karger AG, Basel

References Hardin J, Haber RM. Onychomadesis: literature review. Br J Dermatol. 2015;172(3):592–6. Kim EJ, Park HS, Yoon HS, Cho S. Four cases of onychomadesis after hand-foot-mouth disease. Ann Dermatol. 2014;26(6):777–8. Sechi A, Chessa MA, Leuzzi M, Neri I. Onychomadesis: a rare skin sign occurring after chickenpox. Indian J Dermatol. 2018;63(3):272–3. Relhan V, Goel K, Bansal S, Garg VK. Management of chronic paronychia. Indian J Dermatol. 2014;59(1):15–20. Hadeler E, Morrison BW, Tosti A. A review of nail findings associated with COVID-19 infection. J Eur Acad Dermatol Venereol. 2021;35(11):e699–709. Seshadri D, De D. Nails in nutritional deficiencies. Indian J Dermatol Venereol Leprol. 2012;78:237–41. Damevska K, Gocev G, Pollozahani N, Nikolovska S, Neloska L. Onychomadesis following cutaneous vasculitis. Acta Dermatovenerol Croat. 2017;25(1):77–9. Grover C, Vohra S. Onychomadesis with lichen planus: an under-recognized manifestation. Indian J Dermatol. 2015;60(4):420. Sobolewski P, Walecka I, Dopytalska K. Nail involvement in psoriatic arthritis. Reumatologia. 2017;55(3):131–5. Salgado F, Handler MZ, Schwartz RA. Shedding light on onychomadesis. Cutis. 2017;99(1):33–6. Roest YBM, van Middendorp HT, Evers AWM, van de Kerkhof PCM, Pasch MC. Nail involvement in alopecia areata: a questionnaire-based survey on clinical signs, impact on quality of life and review of the literature. Acta Derm Venereol. 2018;98(2):212–7. Hardin J, Haber RM. Idiopathic sporadic onychomadesis: case report and literature review. Arch Dermatol. 2012;148(6):769–70. Baran R, Goossens A. The nail in occupational, podiatric, and cosmetic conditions. In: Baran R, de Berker D, Holzberg M, Piraccini B, Richert B, Thomas L, editors. Baran & Dawber’s diseases of the nails and their management. 5th ed. Chichester, West Sussex: John Wiley and Sons Inc.; 2019. p. 626–8. NCBI. N-[3-[(2-Chloro-1,3-thiazol-5-yl)methyl]-5-methyl-1,3,5-oxadiazinan-4-ylidene] nitramide_C8H10ClN5O3S-PubChem. 2021. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Thiamethoxam (accessed November 11, 2021. Jayaraj R, Megha P, Sreedev P. Organochlorine pesticides, their toxic effects on living organisms and their fate in the environment. Interdiscip Toxicol. 2016;9(3–4):90–100. Feki A, Ben Saad H, Bkhairia I, Ktari N, Naifar M, Boudawara O, et al. Cardiotoxicity and myocardial infarction-associated DNA damage induced by thiamethoxam in vitro and in vivo: protective role of trigonella foenum-graecum seed-derived polysaccharide. Environ Toxicol. 2019;34(3):271–82. Li M, Chen Z, Yin S, Xue R, Chen Z, Huang H, et al. Onychomycosis secondary to onychomadesis: an underdiagnosed manifestation. Mycoses. 2017;60(3):161–5. Article / Publication Details

First-Page Preview

Received: January 09, 2022
Accepted: February 25, 2022
Published online: May 24, 2022

Number of Print Pages: 5
Number of Figures: 5
Number of Tables: 1

ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)

For additional information: https://www.karger.com/SAD

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.